Globus Medical (GMED) Capital Expenditures Growth (3y) (2014 - 2026)
Globus Medical (GMED) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 9.52% |
| 10 | Globus Medical | 11.64 Bn | 11.04 Bn | 548.17 Mn | 22.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.90% |
| Mar 31, 2026 | 82.73% |
| Dec 31, 2025 | 36.06% |
| Sep 30, 2025 | 106.18% |
| Jun 30, 2025 | -43.48% |
| Mar 31, 2025 | 21.82% |
| Dec 31, 2024 | -93.31% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | 211.80% |
| Mar 31, 2024 | 121.75% |
| Dec 31, 2023 | 17.62% |
| Sep 30, 2023 | -20.86% |
| Jun 30, 2023 | 215.91% |
| Mar 31, 2023 | 7.09% |
| Dec 31, 2022 | 33.17% |
| Sep 30, 2022 | -0.22% |
| Jun 30, 2022 | 17.24% |
| Mar 31, 2022 | -10.82% |
| Dec 31, 2021 | 32.83% |
| Sep 30, 2021 | 3.74% |